The producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets said the grant has a total value of €100,000, on a non-refundable basis, and covers a project which is expected to be concluded within the next 8 months.
As part of the Inno4Cov-19 Project, the grant will be used to assist Directa's research into using graphene technology to help prevent the spread of coronavirus (COVID-19).
This will build on Directa's work undertaken during 2020 to develop the G+ face-mask and G+ filtering system, the AIM-listed firm said.
It noted that the main technical targets of the projects are to undertake the extensive testing and improvement needed to qualify and market G+ enhanced surgical masks, the development of new biodegradable G+ enhanced filters and of a sanification process for the face-mask using household items such as an iron or a hairdryer.
"We are very proud of Directa's contributions so far to the fight against COVID-19. In conjunction with our research partners we have proven that graphene-enhanced materials can hinder the spread of Covid more effectively than other fabrics,” said Directa Plus chief executive Giulio Cesareo in a statement.
"This grant will allow us to invest further and faster in improving the properties of our face-masks, allow us to supply them into clinical settings, and improve the environmental sustainability of their production."
Shares rose 1% to 94p on Wednesday morning.